RECENT NEWS

Aptamer Group, the developer of novel Optimer binders to enable innovation in the life sciences industry, has announced a new partnership with BaseCure Therapeutics for the development of Optimer-targeted gene therapies.

Point-of-care molecular diagnostics company Genedrive has announced that the UK’s National Institute for Health and Care Excellence (NICE) has preliminarily recommended that the Genedrive MT-RNR1 ID Kit can be used by the NHS following the evidence review as part of its Early Value Assessment (EVA) Programme.

Bio-Rad Laboratories has developed partnerships with leading innovative next-generation sequencing (NGS) instrument providers, gaining compatibility of the SEQuoia RNA Sequencing Library Preparation portfolio on new state-of-the-art sequencers, including the Singular Genomics G4 System.

Infonote Datasystems has developed an enhanced version of its Laboratory Information Management System (LIMS) designed specifically to deliver a range of extended features needed across the sector, including the ability to administer and control interactions beyond the immediate laboratory environment.

INTEGRA Biosciences has expanded its range of products to include eight-row and 12-column automation-friendly reagent reservoirs, offering a greater variety of reservoir dimensions to suit the increasing diverse applications of automated workstations.

The 16th International Conference on Molecular Epidemiology and Evolutionary Genetics of Infectious Diseases (MEEGID XVI) will take place on 14-17 November 2023 at the Hilton Dresden, Germany.

Neogap Therapeutics has received approval from the Swedish Medical Products Agency to start a clinical trial of its personalised cell therapy against colorectal cancer. The phase I/IIa trial is planned to be initiated during the first half of 2023.

The medical technology strategy will ensure patients can access safe, effective and innovative equipment and medical devices, and has been welcomed by BIVDA.

US-based diagnostics company Sherlock Biosciences has announced the acquisition of Sense Biodetection, a global molecular diagnostics innovator with headquarters in Oxford.

French rapid test manufacturer Biosynex and Chembio Diagnostics, point-of-care diagnostics company focused on infectious diseases, have announced that the companies are to merge.

Groves Medical Group has started offering Stockholm3 for prostate cancer testing. This is the first UK clinic that uses Stockholm3.

The CFX Opus Deepwell Dx Real-Time PCR System is the latest addition to the Bio-Rad portfolio of real-time PCR instruments. The system offers accurate and precise quantification with flexibility for reactions up to 125 µl in a 96-well format for quantitative PCR (qPCR) diagnostic assays. The CFX Opus Dx Real-Time PCR System is also available in a 96- and 384-well reaction block format.

Pangaea Data, which provides a novel AI-driven product for characterising patients by mapping their journeys and disease trajectories in a privacy-preserving and scalable manner, has announced that it has been named ‘Digital Solution of the Year’ by the UK Government’s Department for International Trade (DIT), as part of its 2023 UK Life Science Innovator Showcase.

Medical diagnostics company Cytovale’s IntelliSep test has received US Food and Drug Administration (FDA) 510(k) clearance to aid in the early detection of sepsis.

This year will be pivotal for many diagnostic companies as they try to navigate the ongoing supply chain issues and the upcoming recession, says GlobalData, a leading data and analytics company.

SmartControl EM from Microgenetics is purpose-built environmental monitoring software that saves time, improves compliance, and empowers quality managers to make better decisions.

Registration is now open for the British Society for Microbial Technology (BSMT) 38th Annual Microbiology Conference, with early bird booking rates available until 10 April.

UK Biocentre is to partner with Eurofins, the world leader in biological testing, to provide high throughput research and clinical genomic services.

Cherwell, a specialist company in cleanroom microbiology solutions has published an update to its guide to ‘Environmental Monitoring Processes and Validation’, incorporating specific detail on the new version of EU GMP Annex 1. This aims to help sterile medicinal product manufacturers with reviewing and improving their environmental monitoring (EM) programs in preparation for compliance with the revised guidelines by August 2023.

Ibex Medical Analytics has announced a new agreement with AstraZeneca and Daiichi Sankyo, for the development, clinical validation and early adoption of an AI-powered product to aid pathologists with an accurate and reproducible assessment of HER2 immunohistochemistry (IHC) scoring in breast cancer patients.